Becker W, Urist M, Becker B E, Jackson W, Parry D A, Bartold M, Vincenzzi G, De Georges D, Niederwanger M
University of Southern California School of Dentistry, Los Angeles, USA.
J Periodontol. 1996 Oct;67(10):1025-33. doi: 10.1902/jop.1996.67.10.1025.
The cases reported in this paper were treated at 7 different clinical centers and present clinical and histologic observations from 15 patients and 21 human biopsies. The biopsies were taken from extraction sockets or dental implant sites which were grafted with either autologous intra-oral bone (6 sites), demineralized freeze-dried bone (DFDBA) (7 sites), or mineralized freeze-dried bone (MFDBA) (7 sites), or a combination of autologous bone, DFDBA and a barrier membrane (1 site). Six sites were grafted with DFDBA and augmented with expanded polytetrafluoroethylene (ePTFE) barrier membranes. Biopsies for histological evaluation were taken 4 to 13 months after implantation. A bone scoring system of 0 to 4 was used to evaluate the sections for dead implanted particles or the presence of vital bone. A bone score of 3 indicated the presence of dead implant material, blood vessels, islands of cartilage, osteoblasts, and new bone formation. A score of 4 indicated total replacement of the implanted material by the host bone. The average bone score for sites which received autologous bone was 2.33; for DFDBA sites, 0.98; and MFDBA was 0.18. The over-riding histologic characteristic of sites implanted with DFDBA or MFDBA was retention of non-vital graft particles within fibrous connective tissue. Biopsies taken adjacent to the host bed demonstrated incorporation of the allografts (osteoconduction). Sites grafted with autologous bone chips also demonstrated non-vital bone chips surrounded by vital host bone (osteoconduction). Sites which received barrier membranes did not appear to improve or impair bone healing of the augmented sites. Autologous bone chips harvested from within the oral cavity as well as allografts may serve as biologic fillers, but do not apparently contribute to osteoinduction. Autologous bone will eventually be resorbed and replaced by the host. DFDBA and MFDBA are resorbed very slowly and apparently do not contribute to osteoinduction. Allografts apparently are not resorbed by osteoclasts and therefore their continued use around dental implants is questioned.
本文报道的病例来自7个不同的临床中心,呈现了15例患者的临床及组织学观察结果以及21份人体活检样本。活检样本取自拔牙窝或牙种植部位,这些部位分别植入了自体口腔内骨(6个部位)、脱矿冻干骨(DFDBA)(7个部位)、矿化冻干骨(MFDBA)(7个部位),或自体骨、DFDBA与屏障膜的组合(1个部位)。6个部位植入了DFDBA并用膨体聚四氟乙烯(ePTFE)屏障膜进行了增量处理。植入后4至13个月进行组织学评估的活检。采用0至4分的骨评分系统评估切片中植入物死亡颗粒或活性骨的存在情况。骨评分为3表示存在死亡的植入材料、血管、软骨岛、成骨细胞和新骨形成。评分为4表示植入材料被宿主骨完全替代。接受自体骨的部位平均骨评分为2.33;DFDBA部位为0.98;MFDBA部位为0.18。植入DFDBA或MFDBA的部位最主要的组织学特征是在纤维结缔组织内保留无活性的移植颗粒。在宿主床附近进行的活检显示同种异体移植物发生了整合(骨传导)。植入自体骨屑的部位也显示无活性的骨屑被活性宿主骨包围(骨传导)。接受屏障膜的部位似乎并未改善或损害增量部位的骨愈合。从口腔内采集的自体骨屑以及同种异体移植物可作为生物填充物,但显然对骨诱导无作用。自体骨最终会被宿主吸收并替代。DFDBA和MFDBA吸收非常缓慢,显然对骨诱导无作用。同种异体移植物显然不会被破骨细胞吸收,因此其在牙种植体周围的持续使用受到质疑。